Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif domain-containing protein 8 (SAMD8), also known as Sphingomyelin synthase-related protein 1 (SMSr), is an endoplasmic reticulum–resident enzyme crucial to sphingolipid metabolism. SAMD8 catalyzes the synthesis of ceramide phosphoethanolamine (CPE) from ceramide and phosphatidylethanolamine, and its activity is essential for maintaining ceramide homeostasis within the ER. By limiting ceramide accumulation and curbing inappropriate signaling events that lead to mitochondrial apoptosis, SAMD8 acts as a critical suppressor of ceramide-induced cell death and is important for early secretory pathway function and overall lipid balance. Disruption or deficiency of SAMD8 is linked to alterations in lipid metabolism, contributing to metabolic conditions such as NAFLD and potentially impacting neurodegenerative or lysosomal storage diseases.
Not established for any approved drugs; putative interventions would likely modulate ceramide or sphingolipid metabolism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif domain-containing protein 8 (SAMD8).